Advertisement

The Role of Cytochrome b5 in Cytochrome P-450 Enzymes

  • H. A. Sasame
  • S. S. Thorgeirsson
  • J. R. Mitchell
  • J. R. Gillette
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 58)

Abstract

The possible involvement of cytochrome b5 in NADPH-mediated cytochrome P-450 reactions in liver microsomes was first suggested by Estabrook and co-workers (1,2). Two years ago we presented immunochemical evidence that the synergistic effect of NADH on NADPH-mediated ethylmorphine metabolism by rat liver microsomes is indeed mediated through cytochrome b5 by showing that an antibody against rat liver cytochrome b5 blocks the increase in NADH-oxi-dation and ethylmorphine N-demethylation in the presence of NADPH, ethylmorphine and liver microsomes (3). We recently presented evidence that a sheep antibody against cytochrome b5 (4,5) also inhibits the omega hydroxylation of lauric acid by rat liver and kidney cortex microsomes in the presence of either NADH or NADPH (Table I). In order to differentiate the inhibitory effect of sheep antibody against cytochrome b5 on the omega hydroxylation of lauric acid from some nonspecific inhibitor present in the antibody preparation, we preincubated the antibody with varying amounts of purified, trypsin-solubilized cytochrome b5 from rat liver and then examined the reversibility of the inhibitory effect.

Keywords

Liver Microsome Lauric Acid Kidney Cortex Sole Electron Donor Sheep Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hildebrandt, A. G. and Estabrook, R. W. Arch. Biochem. Biophys. 143: 66 (1971).PubMedCrossRefGoogle Scholar
  2. 2.
    Cohen, B. S. and Estabrook, R. W. Arch. Biochem. Biophys. 143: 54 (1971).PubMedCrossRefGoogle Scholar
  3. 3.
    Sasame, H., Mitchell, J. R., Thorgeirsson, S. S. and Gillette, J. R. Drug Metabolism and Disposition 1:150 (1973).PubMedGoogle Scholar
  4. 4.
    Sasame, H., Thorgeirsson, S. S., Mitchell, J. R. and Gillette, J. R. Pharmacologist 15: 170 (1973).Google Scholar
  5. 5.
    Sasame, H., Thorgeirsson, S. S., Mitchell, J. R. and Gillette, J. R. Life Sciences 14: 35 (1974).PubMedCrossRefGoogle Scholar
  6. 6.
    Sasame, H. A. and Gillette, J. R. Mol. Pharmacol. 5: 123 (1969).PubMedGoogle Scholar
  7. 7.
    Kornberg, A. J. Biol. Chem. 182: 779 (1950).Google Scholar
  8. 8.
    Nash, T. Biochem. J. 55: 416 (1953).PubMedGoogle Scholar
  9. 9.
    Cooper, J. R. and Brodie, B. B. J. Pharmacol. Exptl. Ther. 114: 409 (1955).Google Scholar
  10. 10.
    Horecker, B. L. and Kornberg, A. in: Methods in Enzymology, Vol. III: 879 Academic Press, New York. (1957).Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • H. A. Sasame
    • 1
  • S. S. Thorgeirsson
    • 1
  • J. R. Mitchell
    • 1
  • J. R. Gillette
    • 1
  1. 1.Laboratory of Chemical Pharmacology, National Heart and Lung InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations